한스바이오메드

042520KOSDAQ의료용품 및 기타 의약 관련제품 제조업

38.0 / 100

Reference Date: 2026-04-13

Financial Score9.5 / 40

News Sentiment12.5 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Plunged 26.5% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

HansBioMed, established in 1999, develops, manufactures, and sells skin and bone tissue implants and medical devices. Its key products, Bella Cell HD and SureFuse, account for approximately 61% of sales, with global expansion through overseas subsidiaries in the U.S., Thailand, and the U.K. The company continues to invest in R&D for regenerative medicine and new medical technologies.

Number of Employees

289people

Average Salary

41.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 19.894.0Point

PBR

13.17Industry Average 1.620.0Point

8.1x industry avg (risky)

ROE

-63.51Industry Average -4.893.5Point

13.0x industry avg (excellent)

Debt Ratio

33.90Industry Average 8.880.0Point

3.8x industry avg (risky)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲7.3% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼2061.7% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -42.1% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 0Neutral 1Negative 0Average Sentiment Score 50

Neutral
라메디텍, 인체조직은행 상반기 가동... ‘연매출 500억’ 돌파 승부...
레이저 미용·의료기기 전문기업 라메디텍이 인체조직은행을 상반기 가동하여 재생의료 시장에 진출하며 외형 성장을 가속화할 계획입니다.

Detailed Momentum

52-week position5.0Point

52w mid range (50%)

Current 31,300Won52-week high 55,70052-week low 6,780

1-month return0.0Point

1m -26.53% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-04-09